Claudio Murgia
Unit Head, Target & Disease Biology, Discovery Oncology Roche
Seminars
Wednesday 2nd December 2026
Insights Exchange – How Can We Better Predict Clinical Success Before the Clinic?
11:40 am
- Which preclinical endpoints, biomarkers, and model characteristics are most consistently associated with successful clinical outcomes?
- How can organisations use clinical observations, imaging, and translational data to improve confidence in model-derived decisions and reduce late-stage risk?
- What are the most common reasons promising preclinical programmes fail in patients, and how can model strategies be refined to improve predictability?
- Audience Q&As
Wednesday 2nd December 2026
Evidence – Harnessing Liquid Biopsy Signals to Advance Early Cancer Detection, MRD Monitoring, & Predictive Disease Modeling
10:50 am
- Translating liquid biopsy insights into preclinical models to detect early tumour evolution and -treatment response
- Modeling Low Tumor Burden and Tumor Developmental Trajectories to Advance Early Cancer -Detection and Therapeutic Index
- Using clinical observational data to refine model systems and enable earlier, more effective intervention strategies
